Organigram Holdings Inc. is a Canadian licensed producer of cannabis, focused on the development and cultivation of high-quality marijuana products for both medical and recreational markets
The company operates state-of-the-art facilities that utilize advanced technology and sustainable practices to grow and produce a variety of cannabis strains, including dried flower and cannabis oils. Organigram is committed to innovation in product development, creating a wide range of cannabis-infused products such as edibles, beverages, and vape oils. With a strong emphasis on compliance, quality control, and consumer education, Organigram aims to be a leading player in the evolving cannabis industry while promoting responsible use and supporting community initiatives.
DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.
Organigram Holdings Inc. (NASDAQOGI) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in Organigram common shares, based on a 30-day trading VWAP of $2.321 on the TSX. An additional CA$10 million contingent consideration is payable in shares, conditional on achieving a share price above $3.2203 within 12 months. The deal is financed through Organigram's cash reserves.
Our Conservative Cannabis Stocks Portfolio has outperformed our Canadian Cannabis LP Stocks Portfolio by more than a 3 to 1 margin on an annual basis. As such, our conservative cannabis portfolio is just that - a conservative cannabis investment.
The Canadian Cannabis LP Stocks Portfolio was up +6% last week from a 10% decline w/e Sept. 6th as the negative sentiment waned surrounding the DEA's announcement that it would be having a December 2nd hearing to consider additional opinions
